Magnetic resonance imaging in duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months

Muscle and Nerve

Volumn 48, Issue 4, 2013, Pages 586-588

  Hollingsworth, Kieren G ^a   Garrood, Penny ^a   Eagle, Michelle ^a   Bushby, Kate ^a   Straub, Volker ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Corticosteroids; Duchenne muscular dystrophy; Fat replacement; Longitudinal; MRI

Indexed keywords

PREDNISOLONE; CORTICOSTEROID;

ARTICLE; BICEPS BRACHII MUSCLE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; FAT CONTENT; GLUTEUS MAXIMUS MUSCLE; HUMAN; LEG MUSCLE; LONGITUDINAL STUDY; LOWER LEG; MALE; MEDICAL HISTORY; MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RECTUS FEMORIS MUSCLE; SCHOOL CHILD; VASTUS LATERALIS MUSCLE; ADIPOSE TISSUE; DEVICES; LEG; MUSCULAR DYSTROPHY, DUCHENNE; PATHOPHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE; TIME; EQUIPMENT; FAT REPLACEMENT; LONGITUDINAL; METHODOLOGY;

ADIPOSE TISSUE; ADRENAL CORTEX HORMONES; CHILD; DISEASE PROGRESSION; HUMANS; LONGITUDINAL STUDIES; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; TIME FACTORS;

CORTICOSTEROIDS; DUCHENNE MUSCULAR DYSTROPHY; FAT REPLACEMENT; LONGITUDINAL; MRI;

EID: 84891505337     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23879     Document Type: Article

References (16)

1. Emery AEH. The muscular dystrophies. Lancet 2002;359:687-695.
2. Hoffman EP, Brown RH, Kunkel LM. Dystrophin-the protein product of the Duchenne muscular-dystrophy locus. Cell 1987;51:919-928.
3. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90:3710-3714.
4. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008(1).
5. Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J. The multidisciplinary management of Duchenne muscular dystrophy. Curr Paediatr 2005;15:292-300.
6. Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 2007;13:520-526.
7. Muntoni F, Wells D. Genetic treatments in muscular dystrophies. Curr Opin Neurol 2007;20:590-594.
8. Fischmann A, Hafner P, Gloor M, Schmid M, Klein A, Pohlman U, et al. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 2013;260:969-974.
9. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, et al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Skelet Radiol 2012;41:955-961.
10. Wren TAL, Bluml S, Tseng-Ong L, Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. Am J Roentgenol 2008;190:W8-12.
11. Bushby K, Muntoni F, Urtizberea A, Hughes R, Griggs R. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands. Neuromuscul Disord 2004;14:526-534.
12. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200.
13. Garrood P, Hollingsworth KG, Eagle M, Aribisala BS, Birchall D, Bushby K, et al. MR imaging in Duchenne muscular dystrophy: quantification of t-1-weighted signal, contrast uptake, and the effects of exercise. J Magn Res Imaging 2009;30:1130-1138.
14. Kobayashi M, Nakamura A, Hasegawa D, Fujita M, Orima H, Takeda SI. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 2009;40:815-826.
15. Walter G, Cordier L, Bloy D, Sweeney HL. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 2005;54:1369-1376.
16. Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skelet Radiol 2005;34:140-148.